E John Pharmaceuticals Limited - Company Profile

It is a trading public limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About E John Pharmaceuticals Limited

E John Pharmaceuticals Limited, a struck off public limited company, was established on 25 January 1985 in Mumbai, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51900MH1985PLC035171. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹1.30 Cr.

Its leadership includes Deepak Rampal (Director), Ashok Upadhyay (Director), Ignatius Martin John (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 105 Earnest House10Th Floor Ncpa Marg, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51900MH1985PLC035171

  • Registration Number

    035171

  • Incorporation Date

    25 January 1985

  • Authorized Capital

    ₹1.30 Cr

  • Paid-Up Capital

    ₹1.30 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.30 Cr
  • Paid Up Capital ₹ 1.30 Cr
  • Company Age 41 Year, 2 Months
  • Last Filing with ROC 31 Mar 2010
Company report

E John Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into E John Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at E John Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Rampal Director 20 Nov 2001 Current
Ashok Upadhyay Director 01 Apr 2004 Current
Ignatius Martin John Director 01 Apr 2004 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of E John Pharmaceuticals.

Enhance accessibility to E John Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

E John Pharmaceuticals revenue growth over time
E John Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of E John Pharmaceuticals?

Unlock access to E John Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at E John Pharmaceuticals?

Unlock and access historical data on people associated with E John Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of E John Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped E John Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on E John Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity E John Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.

  • Balance Sheet

    The activity E John Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Ashok Upadhyay was appointed as a Director was appointed as a Director on 01 Apr 2004 & has been associated with this company since 21 years 11 months . was documented.

  • Director Appointment

    Progress on Ignatius Martin John was appointed as a Director was appointed as a Director on 01 Apr 2004 & has been associated with this company since 21 years 11 months . was documented.

  • Director Appointment

    Deepak Rampal was appointed as a Director was appointed as a Director on 20 Nov 2001 & has been associated with this company since 24 years 4 months . was recorded as a recent event.

  • Company Incorporation

    The activity E John Pharmaceuticals Limited was registered on 25 Jan 1985 with Roc Mumbai & aged 41 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of E John Pharmaceuticals Limited?

The CIN of E John Pharmaceuticals Limited is U51900MH1985PLC035171.

Where is E John Pharmaceuticals Limited headquartered?

E John Pharmaceuticals Limited is headquartered at 105 Earnest House10Th Floor Ncpa Marg, Mumbai, Maharashtra, 400021.

When was E John Pharmaceuticals Limited incorporated?

E John Pharmaceuticals Limited was incorporated on 25 January 1985.

Who are the current directors of E John Pharmaceuticals Limited?

The current directors of E John Pharmaceuticals Limited are

What is the primary industry of E John Pharmaceuticals Limited?

The primary industry of E John Pharmaceuticals Limited is Trading.

Is E John Pharmaceuticals Limited a listed company?

E John Pharmaceuticals Limited is unlisted.

What is the capital structure of E John Pharmaceuticals Limited?

The authorized capital of E John Pharmaceuticals Limited is ₹1.30 Cr, and the paid-up capital is ₹1.30 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available